Client Extranet
|
Site Map
|
RSS
About Us
Practices
People
Offices
News & Insights
Alumni
Careers
Blogger
Delicious
Digg
Facebook
LinkedIn
Twitter
Email
Home
»
Practices
»
Technology Transactions
» News & Insights
Technology Transactions
RELATED AREAS
Copyright
Corporate Finance
Corporate Governance
E-Commerce
Joint Ventures
Mergers & Acquisitions
Patents
Private Equity
Trademarks/False Advertising
All Practices
Select a Practice
CLOSE [x]
Antitrust
Antitrust & Intellectual Property
Antitrust Counseling
Antitrust Energy Counsel
Cartel Investigations and Criminal Litigation
Complex Civil Antitrust Litigation
Healthcare Antitrust
Mergers, Acquisitions, Joint Ventures and Strategic Alliances
Pharmaceutical Antitrust Solutions
Appellate Litigation
Asian Practice
Asset Management & Private Funds
Bankruptcy / Financial Restructuring
Climate Change
Commercial Disputes Litigation
Congressional Investigations
Construction and Procurement
Construction Litigation
Consumer Class Action
Copyright
Corporate Espionage & Competitive Intelligence
Corporate Finance
Alternative Investment Market - AIM
Corporate Governance
Corporate Plaintiffs Litigation
Directors' & Officers' Liability Litigation
Domestic Arbitration / ADR
E-Commerce
E-Discovery
Emerging Growth Companies
Employee Benefits / Compensation
Energy and Natural Resources
Energy: Arbitration
Energy: Construction and Procurement
Energy: Construction Dispute Resolution
Energy: Environmental Litigation
Energy: Finance
Energy: Financial Restructuring
Energy: Foreign Corrupt Practices Act
Energy: Intellectual Property
Energy: LNG
Energy: Maritime
Energy: Mergers and Acquisitions
Energy: Nuclear
Energy: Oil and Gas Litigation
Energy: Petrochemical
Energy: Power
Energy: Power Litigation
Energy: Private Equity
Energy: Project Development
Energy: Regulatory
Energy: Renewable and Alternative
Energy: Tax
Energy: Tort Litigation
Oil & Gas: Exploration and Production
Oil & Gas: Midstream and Pipelines
Oil & Gas: Oil Field Services
Oil & Gas: Refining
Environmental
Environmental Litigation
ERISA & Employee Benefits Litigation
FDA & Life Sciences Practice
Financial Markets Task Force
Distressed Assets Task Force
Financial Markets Policy Task Force
Subprime and Capital Markets
Financial Products Litigation
Financial Services
First Amendment/Defamation Litigation
Franchise & Distribution
Franchise & Distribution Litigation
German Practice
Global Islamic Finance & Investment
Middle East & North Africa
Middle East Asset Finances
Middle East Arbitration
Middle East Energy
Middle East Healthcare
Middle East M&A and Private Equity
Middle East Power and Water
Middle East Project Finance
Middle East Projects and Construction
Middle East Real Estate
Pertochemicals and Refining
Private Equity and Investment Funds
Saudi Arabia Practice
Government Advocacy & Public Policy
Healthcare Industry
Academic Medical Centers
Children’s Health
Civil Litigation
Class Actions
Clinical Research Compliance
Financial Restructuring
Government Advocacy & Public Policy
Government Investigations and False Claims Act Defense
Health Information Technology and Electronic Health Records
Healthcare Antitrust
International Healthcare
Labor & Employment
Managed Care, Health Plans and Insurers
Mergers, Acquisitions and Other Transactions
Private Equity
Provider Representation and Counseling
RAC & MIC Audits and Appeals
Regulatory and Compliance
Reimbursement
Tax
Tax Exempt Bond Financings
Healthcare Litigation
Homeland Security
Infrastructure Finance and Development
Insurance Coverage and Recovery
Intellectual Property Litigation
International
International Arbitration
International Trade / WTO
Joint Ventures / Strategic Alliances
Labor & Employment Litigation
Latin American Practice
Licensing
Marketing & Advertising Litigation
Mass Tort
Mergers & Acquisitions
Our Approach to Litigation
Outsourcing
Patents
Pharmaceutical / Biotechnology / Medical Devices
Pharma: Antitrust
Pharma: Business Litigation
Pharma: Corporate
Pharma: Emerging Companies
Pharma: FDA & Life Sciences
Pharma: Government Advocacy & Public Policy
Pharma: Government Investigations
Pharma: Intellectual Property
Pharma: International Arbitration
Pharma: Labor & Employment
Pharma: Products Liability / Mass Tort
Privacy & Information Security
Private Equity & Investment Funds
Private Finance
Product Liability Litigation
Professional Liability Litigation
Project & Equipment Finance
Public Finance
Real Estate & Real Estate Capital Markets
Russia Practice
Securities Litigation / Directors' & Officers' Liability
Special Matters / Government Investigations
Sports, Media & Entertainment Practice
Tax
Tax Litigation
Tax-Exempt
Technology Transactions
Telecommunications
Toxic Tort Litigation
Trade Secrets & Non-Compete Litigation
Trademarks and False Advertising
Overview
|
People
|
Matters
|
News & Insights
|
NEWS
More
28 Mar 2013
RECOGNITION
Latest Legal 500 Guide Reinforces King & Spalding’s Growing Profile in Europe, the Middle East and Africa
29 Oct 2012
PRESS RELEASE
King & Spalding Adds Top Deals Lawyer Judy O’Brien
24 Sep 2012
PRESS RELEASE
King & Spalding adds IP Transactions Specialist in Silicon Valley
17 Feb 2012
IN THE PRESS
|
Fulton County Daily Report
King & Spalding Reports Another Fat Year
PUBLICATIONS
More
20 Jan 2010
ARTICLE
|
Harvard Law School Forum on Corporate Governance
The Board's Role in Succession Planning
03 Jan 2010
ARTICLE
|
Harvard Law School Forum
Drafting Disclosure Relating to Board Leadership and Risk Oversight
08 Aug 2009
ARTICLE
|
Harvard Law School Forum
The Board's Role In Risk Management
27 Feb 2004
CLIENT ALERT
Recent Outsourcing Legislation Restricts Offshoring
Jack D Capers Jr.
T: +1 404 572 4658
ATLANTA
